HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
Clinical trial NCT04513626 · RECRUITING
Trial details
- NCT number
- NCT04513626
- Sponsor
- Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2025-10-30
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.